elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39095194-B02A6B47-711D-47C4-86BF-B46627BDB87C
Q39095194-B02A6B47-711D-47C4-86BF-B46627BDB87C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39095194-B02A6B47-711D-47C4-86BF-B46627BDB87C
Pharmacotherapy for treating metastatic clear cell renal cell carcinoma.
P2860
Q39095194-B02A6B47-711D-47C4-86BF-B46627BDB87C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39095194-B02A6B47-711D-47C4-86BF-B46627BDB87C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6c3e19c2c7178bba521035af70e6ef014607f11a
P2860
A phase I study of cabozantinib (XL184) in patients with renal cell cancer.